A Multicenter Epidemiological Study on Second Malignancy in Non-Syndromic Pheochromocytoma/Paraganglioma Patients in Italy
Authors:
- Letizia CanuLetizia Canu
- Soraya PuglisiSoraya Puglisi
- Paola BerchiallaPaola Berchialla
- Giuseppina De FilpoGFGiuseppina De Filpo
- Francesca BrignardelloFBFrancesca Brignardello
- Francesca SchiaviFrancesca Schiavi
- Alfonso Massimiliano FerraraAFAlfonso Massimiliano Ferrara
- Stefania ZovatoSZStefania Zovato
- Michaela LuconiMichaela Luconi
- Anna PiaAPAnna Pia
- Marialuisa AppetecchiaMAMarialuisa Appetecchia
- Emanuela ArvatEAEmanuela Arvat
Open Access
Abstract
No studies have carried out an extensive analysis of the possible association between non-syndromic pheochromocytomas and paragangliomas (PPGLs) and other malignancies. To assess >the risk of additional malignancy in PPGL, we retrospectively evaluated 741 patients with PPGLs followed-up in twelve referral centers in Italy. Incidence of second malignant tumors was compared between this cohort and Italian patients with two subsequent malignancies. Among our patients, 95 (12.8%) developed a second malignant tumor, which were mainly prostate, colorectal and lung/bronchial cancers in males, breast cancer, differentiated thyroid cancer and melanoma in females. The standardized incidence ratio was 9.59 (95% CI 5.46–15.71) in males and 13.21 (95% CI 7.52–21.63) in females. At multivariable analysis, the risk of developing a second malignant tumor increased with age at diagnosis (HR 2.50, 95% CI 1.15–5.44, p = 0.021 for 50–59 vs. p < 0.001 for >60- vs. p = 0.003). In conclusion, PPGLs patients have higher incidence of additional malignant tumors compared to the general population who had a first malignancy, which could have an impact on the surveillance strategy.Keywords
Funding Information
- Associazione Italiana per la Ricerca sul Cancro (IG-2020-ID.24820)
- Ministero dell’Istruzione, dell’Università e della Ricerca (Departments of Excellence 2018-2022)
- Ricerca Locale Università di Torino 2020 (RILO 2020)
This publication has 35 references indexed in Scilit:
- Recurrent epimutation ofSDHCin gastrointestinal stromal tumorsScience Translational Medicine, 2014
- Succinate dehydrogenase deficient gastrointestinal stromal tumors (GISTs) – A reviewThe International Journal of Biochemistry & Cell Biology, 2014
- Exploring the association of succinate dehydrogenase complex mutations with lymphoid malignanciesFamilial Cancer, 2014
- Pheochromocytoma and paraganglioma pathogenesis: learning from genetic heterogeneityNature Reviews Cancer, 2014
- Mapping of Succinate Dehydrogenase Losses in 2258 Epithelial NeoplasmsApplied Immunohistochemistry & Molecular Morphology, 2014
- A novel recurrent mutation in MITF predisposes to familial and sporadic melanomaNature, 2011
- A SUMOylation-defective MITF germline mutation predisposes to melanoma and renal carcinomaNature, 2011
- Mortality Associated with PheochromocytomaAnnals of the New York Academy of Sciences, 2006
- PhaeochromocytomaThe Lancet, 2005
- Early-Onset Renal Cell Carcinoma as a Novel Extraparaganglial Component of SDHB-Associated Heritable ParagangliomaThe American Journal of Human Genetics, 2004